Received: from ExMB4.ph.ee ([172.20.7.194]) by ExMB4.ph.ee ([172.20.7.194]) with mapi id 15.02.2562.053; Mon, 12 Oct 2026 23:17:15 +0300 Received: from mail1.rit.ee (213.184.53.4) by MI3PEPF0000847D.mail.protection.outlook.com (10.167.240.164) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.522.6 via Frontend Transport; Mon, 12 Oct 2026 20:17:42 +0000 Received: from pps.filterd (pp-client-1.ph.ee [127.0.0.1]) by pp-client-1.ph.ee (8.18.1.11/8.18.1.11) with ESMTP id 69CKA7f42898936; Mon, 12 Oct 2026 23:17:26 +0300 Received: from ExMB4.ph.ee (172.20.7.194) by ExMB1.ph.ee (172.20.7.191) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.2.2562.49; Mon, 12 Oct 2026 23:17:15 +0300 Received: from exmb1.ph.ee (smtp.ph.ee [194.126.127.51]) by pp-client-1.ph.ee (PPS) with ESMTPS id 4h78ex862j-1 (version=TLSv1.2 cipher=ECDHE-RSA-AES256-GCM-SHA384 bits=256 verify=NOT); Mon, 12 Oct 2026 23:17:16 +0300 (EEST) Received: from MI3PEPF0000847D.eurprd02.prod.outlook.com (2603:10a6:102:34a:cafe::ab) by PA7P264CA0052.outlook.office365.com (2603:10a6:102:34a::13) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.496.5 via Frontend Transport; Mon, 12 Oct 2026 20:17:42 +0000 Received: from GV1PR02MB11143.eurprd02.prod.outlook.com (2603:10a6:150:1ee::5) by VI1PR02MB5760.eurprd02.prod.outlook.com with HTTPS; Mon, 12 Oct 2026 20:17:47 +0000 Received: from PA7P264CA0052.FRAP264.PROD.OUTLOOK.COM (2603:10a6:102:34a::13) by GV1PR02MB11143.eurprd02.prod.outlook.com (2603:10a6:150:1ee::5) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.496.23; Mon, 12 Oct 2026 20:17:42 +0000 From: "Ines Vaide" To: "Info - TA" Cc: =?Windows-1252?Q?Eesti_Hemofiilia=FChing?= , Subject: Kutse esinema Nordic-Baltic Meeting 2027, Tallinn 12-14.03.2027 Date: Mon, 12 Oct 2026 23:17:15 +0300 Message-ID: <98c8b810860846b09f8e4e5c518276bf@ph.ee> MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_006C_01DD5AE6.8958F7B0" X-Mailer: Microsoft Outlook 16.0 Thread-Index: AQDxXyFtAQUtkDmwlHL9nmYQMBuBSw== Authentication-Results: mx.microsoft.com 1; spf=fail (sender IP is 213.184.53.4) smtp.mailfrom=ph.ee; dkim=pass (signature was verified) header.d=ph.ee;dmarc=pass action=none header.from=ph.ee;compauth=pass reason=100 X-CSE-ConnectionGUID: /WC6RohXQxGVYEYT+8jlMQ== X-CSE-MsgGUID: 6nz5L1mhTsaMKRmtprt4ew== X-ThreatScanner-Verdict: Negative X-IPAS-Result: =?us-ascii?q?A0GOGADBP81qdzx/fsJaHgE8DAILgWQDgTsbAgEBAQE6K?= =?us-ascii?q?YFZExEiBAtJHYxYXYsim3WBewIPAQEBAQEBAQEIAQEUEygCBAEBAwEDhH6OF?= =?us-ascii?q?SAHATwCDQECAQIBAwIDAQEBAQEBAQEBAQEBCgEBAQQBAQECAQECBAMBAQEBA?= =?us-ascii?q?hABQ0mGTwEMjBM7ghYsgQ1EAQE3AREBDHMnBA4NhRgMCkEHvUGBNIEBggwBA?= =?us-ascii?q?QYEAwID3CiBawmBSwMBAQEBAYUAbIJtASuBNQGEFwE4g0l7NoFVRCaDaYVeh?= =?us-ascii?q?hmCJnoSG4MMGZJyLIEYIgMmMywBD0YTFwsHBYFmAyovLW4yHYEjPhcIJ1gbB?= =?us-ascii?q?gWBHYEgghYjGTZ6gQlegSspYAEQF4EJggcCglSCAAIBSUEOB0VTCSVDEkcmI?= =?us-ascii?q?ggSCQETGjALgRs4PAkoQRcMdAwdBRgHZj03FRkGAYE1kEJhHoIegRSBQg4dl?= =?us-ascii?q?EOPdI5glGM0B4QhBYFbBgyfci4XhASNFJlXmQgjqHUCBAIEBQIYghYMgVwzG?= =?us-ascii?q?oNaUAMXAg+PWAECgzXLLUQ1PQEBBwIHDgMLgWiDf4w1LgE9YAEB?= X-Talos-CUID: 9a23:NzudQW+dlPGIYelHueGVvwkrMZ4fdX3t9Wf/HX6VOFoqGL+RbGbFrQ== X-Talos-MUID: 9a23:YZg3AQTNeqwZVwvFRXSygiM/EJ5t45i1AWUuq5Aao9OYaSFvbmI= X-IronPort-Anti-Spam-Filtered: true X-IronPort-AV: E=Sophos;i="6.27,154,1787000400"; d="scan'208,217";a="82805725" X-Amp-Result: SKIPPED(no attachment in message) X-Amp-File-Uploaded: False X-MS-Exchange-Organization-ExpirationStartTime: 12 Oct 2026 20:17:42.2358 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Exchange-Organization-Network-Message-Id: 7ac89f01-a477-466b-72e1-08df289ddec5 X-EOPAttributedMessage: 0 X-EOPTenantAttributedMessage: 8fe098d2-428d-4bd4-9803-7195fe96f0e2:0 X-MS-Exchange-Organization-MessageDirectionality: Incoming X-MS-PublicTrafficType: Email X-MS-TrafficTypeDiagnostic: MI3PEPF0000847D:EE_|GV1PR02MB11143:EE_|VI1PR02MB5760:EE_ X-MS-Exchange-Organization-AuthSource: MI3PEPF0000847D.eurprd02.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Anonymous X-MS-Office365-Filtering-Correlation-Id: 7ac89f01-a477-466b-72e1-08df289ddec5 X-MS-Exchange-AtpMessageProperties: SA|SL X-DisclaimerOO: 1 X-MS-Exchange-Organization-SCL: -1 X-Microsoft-Antispam: BCL:0;ARA:13230040|260918215300599003|260918224100599003|82310400026|31052699007|19002099009|8096899003|10067099003|18003699003|261009223027099003|11063799006|5063699009|56012099006|55112099003|16102099003; X-Forefront-Antispam-Report: CIP:213.184.53.4;CTRY:EE;LANG:et;SCL:-1;SRV:;IPV:CAL;SFV:NSPM;H:mail1.rit.ee;PTR:mail1.rit.ee;CAT:NONE;SFS:(13230040)(260918215300599003)(260918224100599003)(82310400026)(31052699007)(19002099009)(8096899003)(10067099003)(18003699003)(261009223027099003)(11063799006)(5063699009)(56012099006)(55112099003)(16102099003);DIR:INB; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 12 Oct 2026 20:17:42.0599 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: 7ac89f01-a477-466b-72e1-08df289ddec5 X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2 X-MS-Exchange-CrossTenant-AuthSource: MI3PEPF0000847D.eurprd02.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Anonymous X-MS-Exchange-CrossTenant-FromEntityHeader: Internet X-MS-Exchange-Transport-CrossTenantHeadersStamped: GV1PR02MB11143 X-MS-Exchange-Transport-EndToEndLatency: 00:00:05.1141980 X-MS-Exchange-Processed-By-BccFoldering: 15.21.0496.018 X-MS-Exchange-ExternalInOutlookResult: NotEnabled X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(4710232)(4717077)(4999285)(920097)(930201)(20251009284)(140003); X-Microsoft-Antispam-Message-Info: =?us-ascii?Q?/3nRVdAXiBOQGvc69guHeE+9obQ073lmUNMq/UQLxb1TZKi56AwbkNCq0aVb?= =?us-ascii?Q?1a11rTR72HmztBSlgmLCHL6+D11URWHAJHvh2ddITAjy7CD9pqDqu4mvybdk?= =?us-ascii?Q?b9tBqQmIZ0jJc6DRp8WdMkAcuGIMDw3xa0pdMVXSHPqlRBXIgS7BhmklGD/A?= =?us-ascii?Q?bH+NKiNB7tafAkIvcovScOp4dURCB1ZonAx4dsayLxsMZKA+/7uW8Ff4LdsX?= =?us-ascii?Q?1EkbCI7ioDuB9vN/0+lA8QOhBxeJkKUFwNzxJJ/0NhEXO7g1J6jatWB2Q5ih?= =?us-ascii?Q?3GWu5swJJfCxnQNeE1Bii787vgfamoOZoQJ8/j5x6TpQHgOr+CiJt4S2U1x2?= =?us-ascii?Q?yWXznKZdjjhXmaLnfO2PKZKTuk6la24NrF2UIh2FY3iQhZ+BTmyUan/xjRSD?= =?us-ascii?Q?F1vLKBzX7Km//DYY+2NOVCqATUn3yw0hsVqv83HjOu1nuqNrbZ0bCQLS4VQI?= =?us-ascii?Q?mbGFGXDle1L+NW5mYWLwN4Hu9nugzAcl3J+KDono87gs8TwPpbAamU22D7IR?= =?us-ascii?Q?zHZMNtn/VzN9zsH7QgXDxJQuHXq9b5OR7Got9YwP48a+1n3GkYYyJH4USeqH?= =?us-ascii?Q?hcZe6wPiANAoEbAZsfte+r93eG20YMoF4wODR27sPLGUSfSCK/ld4fdHkP5V?= =?us-ascii?Q?SlGx+5cbiTIC9VRynI9c594HLnBTIYvX6XrmbLAL5c2+RuuObY8qcrTiv98b?= =?us-ascii?Q?ysJGiQcldZ3LBDZMmFpRdxD4ZJLjF1HJOijg6h5BCawGFCdKTI8 HQOQwUSSe?= =?us-ascii?Q?GVrqYWr9MrCksrvRkUe/02Ywx5mDHRBb5YxWhknJe0Xv8QbBUQsr1SWmvK4R?= =?us-ascii?Q?qa8sednGOszj4321f0nHxh8S4EadZHqsCLcTupxh6qwnCTRLap1oZxZ4aHhb?= =?us-ascii?Q?2uOy/MtK9/NNXVJd0dvlMk+nbMncpJaQjmoEsS5FroT/WagFOhJJUEefQ5ur?= =?us-ascii?Q?tDn/qRA9c6T4IzMh943ZzS/veJeIuB/xasAqtUqC242KLsvvSzFfQSRUNNC5?= =?us-ascii?Q?JCdEfyEE6LcYw8rRrTf49LqEgk7DLOmTL/XTp1fiW77ugMviLgKjd/Fg4Gtv?= =?us-ascii?Q?rNAG31DmFrHYQR2owP4lAheOSOKZIsBeGLKcilV4eLTezZYh/a2WHn125/Ov?= =?us-ascii?Q?Hskp94rX3S9CmmEQPdssQU8dXSUgqr7IxJNABNQ0VBRbn3qjZztcLWap0akP?= =?us-ascii?Q?yjYF+tj0B4CbmjjML7j9dTgWgGc+e0xNbEqS9YNFbnTmjyo3IAM9qUC5PxOT?= =?us-ascii?Q?9XaXt2MhiH4Uxfei3Uin7GssHCg59znq/dIlA12d30fVcPHZjt8QcrgiK3dM?= =?us-ascii?Q?dZCV7wv1GGl8UoYnjyXuVvX+SbGFE2HFMoFmB+njjk6i23HVe6RyFxj0RK1W?= =?us-ascii?Q?/mhB0y0a7El4I4lWhHRfKQSVJxFde6DdjsNirraeCHPTwRdgBx5n+qvvTWt5?= =?us-ascii?Q?LtHBcLYVSN1C7dB39smL2SBC0nFQ9mdj7dZNpZhvrfBPDeMWf6rzWMZjyZ4T?= =?us-ascii?Q?9cAeEjbmUM+AKt3VYtM6c2igvBH0MJ90WEczl 6RSIcIRk4O6whBnsAQtwLyr?= =?us-ascii?Q?ORxI1HgRkZSlI467ci9/orNv8J/FN0+5jk84G+v/CMZ3QXpjoZgKZETS++lo?= =?us-ascii?Q?jNfva2ZaAR/E8egArLV/dNsn4Lf2Y05MDZG7TdXtUktvnQgSRnDusFANEJj2?= =?us-ascii?Q?hba1eR3lp8nP9QIQtqovhjsCVyxtLXTRDGjXf/4KkomvIr4buFU6jNwy0f8v?= =?us-ascii?Q?7KC2zJgYzCe0YJQJtxc2RW2TtvGPAbwbyutDZBfJqqXzQeJFUOPy4loUpoJN?= =?us-ascii?Q?QZEpZ38C+4nzMmnUDouvFvvNVQbdqRIPR+uSF/k7JDaj32ewcTpaJYWuZOcf?= =?us-ascii?Q?R7VV9sKhLvVx6Ry3h5YAvAzL39KIIncldY1Z3gwijR7rQC/eCTmUEk9Bj0Aa?= =?us-ascii?Q?oaPp+v2n+ZxWkYsBD36sAQ4a9MUKiU0TTlvPWnVa30jdZ+Epc//zVYh+CYCQ?= =?us-ascii?Q?XneHYRfMIEvSungfCg0tIrIk96elWY9LpSnilRxGY1Nkb+mOAUbTinGsQqr7?= =?us-ascii?Q?0CAgoUSZA1d921+PuCzG69Jide5TcoOzyDr6CaXQSDbSGYIRXBxXBqutGbkJ?= =?us-ascii?Q?8ledVuIi1QhFl4i0MIzptVhucEFIN/jn08Rm+JL7fTocRm6Hu4pHXbg1QlPJ?= =?us-ascii?Q?cN0UyUJ7fLoA0lruaotyHzz979uR60vtvRhTyLujPzjaSEdyTBTRDshgxtn6?= =?us-ascii?Q?8ZwjL1BpUaWjdJ5285bh2gduD5kuNAGE8m2bcCmWQW+VAYutDS429TpFQwva?= =?us-ascii?Q?GOqLF9wcptASNaOHjNBm+OJ vilRNDawQrUHxDKL377GNMSyCWGhR/7keLHK3?= =?us-ascii?Q?nXdVEl5lqpF6WUFCLYWgARHVDBsG/stj/OEH2JYa0/f9Vwxh5SDZ4AtLmHCO?= =?us-ascii?Q?Ir9ffEy8/aNZTAEiAT4xsQs9vc+YKKBmnkU7X7toHfLaHYIX8c/rVcC+v33i?= =?us-ascii?Q?gBYRNHexiCXW3Q/hiHc57rbWZpMc2TmqCNXf8QlFES33emX+GNu0DlxWRWg/?= =?us-ascii?Q?SeO0XU0EL3XTZZ2VsBaD9F6pd/FoBul/LjnZ+N+O+m8E692xAcOPDxLkYvIh?= =?us-ascii?Q?X/4LgpCtTtk/2AxAx3xjicsHs9vIDw9XoyMmmVOZlANBySj7uQaucBM32dWT?= =?us-ascii?Q?dSY66bVm9DfMqPCtCinknshcVhbBKxpN/1IC0jP6YseINZuQ+2SYQ6Wm81Zs?= =?us-ascii?Q?qa8V5Umzzx956Tib0ckP3X7kz9msrY4kegrV01Y3Q8YJwPg+xQbQrsf2Ep63?= =?us-ascii?Q?KbI9U2N5Vml2MD5tOUbSCqEjWU1Ji2RtPJwrjoFGitEsj+wQpVwajVQjdWP4?= =?us-ascii?Q?JejPQVTWrSmK2Kea6Q=3D=3D?= Content-Language: et x-ms-exchange-organization-originalclientipaddress: 213.184.53.4 x-ms-exchange-organization-originalserveripaddress: 10.167.240.164 dkim-signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=ph.ee; h=cc :content-type:date:from:message-id:mime-version:subject:to; s= smtp; bh=hu0sHf3jcAeEfGhhrcOIAHIPHFtkiFRxliorDL3ReRQ=; b=zuv5Fuu oOygeuxv1w6tl5NCAh0DGu6z1KvoQQqn2fFH5M+Vj4S8GHMrVBf7YFePocpy7qRZ rM+qpDo8Az+bp4HiuPT2A/YEt+EUlVMWHYP0vnZU8PhARdcpBJfEsn1tnZa3CMpa heSy6nlVdDToUwQ+j0mc5LKitz0R9LbVKMQKcb2wlBYyIBl9Lm5a+TCQ2WNXH90r izfrX14PzWTxKVWNaiWHt/0weF3ZoOh2vyCTW1FuTnIqELQCxXriseoN1rm0EjmQ tsA1PZ8UTsvwAV95JZPeFUyrkpMZPeja+ZlebVQlK7N3tYCJf+9c+YZBZUC+3WMg 0vrEnpfqXtk6FCw== received-spf: None (mail1.rit.ee: no sender authenticity information available from domain of postmaster@pp-client-1.ph.ee) identity=helo; client-ip=194.126.127.60; receiver=mail1.rit.ee; envelope-from="ines.vaide@ph.ee"; x-sender="postmaster@pp-client-1.ph.ee"; x-conformance=spf_only X-OlkEid: 00000000659667818E23294FBABFF2B20EE82585070034AD76187591974DBF6C4F76951C873A010002000000000029E7021DF49ECF449E6722D8A36C5D9200000000300C0000FAFDC0A2AF1F05459FC4C00DD48D4864 X-MS-Has-Attach: X-MS-TNEF-Correlator: acceptlanguage: et-EE, en-US x-originating-ip: [46.131.89.128] X-Proofpoint-Spam-Info: AW1haW4tMjYxMDEyMDA4MCBTYWx0ZWRfX1HlUCU0X7/AB 5wKcpycncpeq6gfFWEbJcpFTnN/WJUziVrkDz5ag/hD0aXDTcvWaLcwD7qipGTsf2GcroBkxbYO KHOACQ6WDC/FL/tIUDWwo4sYleptHfaTCB2GG4lX+g8KEHASGY1S X-Proofpoint-Spam-Details-Enc: AW1haW4tMjYxMDEyMDA4MCBTYWx0ZWRfX0WLhHuG8zWvf KxeJu2RYEjxkZruIkpUlzmUWH78EGRrJ/HfCE+Xa9yv6GWXQDDs0PFd3aTVSl6CnojX+uCnf9h9 +mrCEcy8MAg/YdmFhQu6lQAh/Z+xrTn2jMNCy9FtNHf0RhZ3b+46cL8D4Bc3ZU5OTjUAWlO5LPS D6nvipB++KEPad/iL2OxgMTEeZev5RzDBeVcWAoe6Eg6yn1D458+jo7HDqEkHfaf6FK2NzHjmyi pA6x654BM+DQ0vo63oxwsQCZXcIO6rSLi+lz5to/ugjPK0CtMcJlj0+IkFrtDxrvkHQG9rmXr7e cTfl/i1DfGDmQV+0q4KBLt8T6WjJcSE/jdQ7J2mvdMNVsx1FE0fXc/bxo5G6McQfh/3Jjhmt3Go gk+F9fhbLEUgVkitg2tmtRhutattEg== X-Authority-Analysis: v=2.4 cv=PdVqFShd c=1 sm=1 tr=0 ts=6acd404c cx=c_pps a=le84jSDIpmDhjp19lpGFxA==:117 a=0BAKxDeZEe0A:10 a=660iZSQnnn4A:10 a=VkNPw1HP01LnGYTKEx00:22 a=Iwic4pHs_bkqg1F8IN4f:22 a=NChB7CJbEIVCwtJyUgVS:22 a=6RkHAO6pzgp7Z6T5RiAA:9 a=pILNOxqGKmIA:10 a=pHdkW7Yo5XpuW84x1TcA:9 a=3OlvfKmizyRhdp-e:21 a=frz4AuCg-hUA:10 a=_W_S_7VecoQA:10 X-Proofpoint-GUID: nLO5LEzdTwSul5w_ljfqNGeoUjH4pObr X-Proofpoint-ORIG-GUID: nLO5LEzdTwSul5w_ljfqNGeoUjH4pObr This is a multipart message in MIME format. ------=_NextPart_000_006C_01DD5AE6.8958F7B0 Content-Type: text/plain; charset="Windows-1252" Content-Transfer-Encoding: 8bit Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Lugupeetud Terviseamet! Kirjutan Teile Eesti Hemofiiliaühingu juhatuse nimel sooviga kutsuda Terviseameti esindajat esinema ingliskeelse ettekandega meie Nordic-Baltic Meeting 2027-l, mis toimub 12.–14. märtsil 2027 Tallinnas Palace hotellis. Tegemist on iga-aastase Põhja- ja Baltimaade veritsushäiretega inimeste patsientide organisatsioonide ühisseminariga, mida korraldatakse igal aastal rotatsiooni korras erinevas Põhjamaa riigis. 2027. aastal toimub kohtumine esmakordselt Baltimaades, Tallinnas. Palume Teil teha ettekanne, mis käsitleks ravimite kättesaadavust kriisiolukordades. Tegemist on olulise teemaga, mis puudutab kõiki kohtumisel osalevaid riike. Ettekande kestus võiks olla ligikaudu 30 minutit, millele järgneks lühike küsimuste-vastuste voor. Plaani järgi toimuks ettekanne 13.03.2027 Jääme ootama Teie vastust ning oleme väga tänulikud, kui leiate võimaluse meie seminaril ettekandega osaleda. Heade soovidega! Ines Vaide Hematoloog Tel +372 5650 0074 This e-mail and any attachment may contain confidential and privileged information. If you are not the intended recipient,please notify the sender immediately by return e-mail, delete this e-mail and destroy any copies. Any dissemination or use of this information by a person other than the intended recipients is unauthorized and may be illegal. ------=_NextPart_000_006C_01DD5AE6.8958F7B0 Content-Type: text/html; charset="Windows-1252" Content-Transfer-Encoding: quoted-printable

T=E4helepanu! Tegemist on v=E4lisv=F5rgust saabunud kirjaga.
Tundmatu saatja korral palume linke ja faile mitte = avada.

Lugupeetud Terviseamet!


Kirjutan Teile Eesti Hemofiilia=FChingu juhatuse nimel sooviga = kutsuda Terviseameti esindajat esinema ingliskeelse ettekandega meie = Nordic-Baltic Meeting 2027-l, mis toimub 12.=9614. m=E4rtsil 2027 = Tallinnas Palace hotellis.


Tegemist on iga-aastase P=F5hja- ja Baltimaade veritsush=E4iretega = inimeste patsientide organisatsioonide =FChisseminariga, mida = korraldatakse igal aastal rotatsiooni korras erinevas P=F5hjamaa = riigis. 

2027. aastal toimub kohtumine esmakordselt Baltimaades, = Tallinnas.


Palume Teil teha ettekanne, mis k=E4sitleks ravimite = k=E4ttesaadavust kriisiolukordades. Tegemist on olulise teemaga, mis = puudutab k=F5iki kohtumisel osalevaid riike.

Ettekande kestus v=F5iks olla ligikaudu 30 minutit, millele = j=E4rgneks l=FChike k=FCsimuste-vastuste voor. Plaani j=E4rgi toimuks = ettekanne 13.03.2027


J=E4=E4me ootama Teie vastust ning oleme v=E4ga t=E4nulikud, kui = leiate v=F5imaluse meie seminaril ettekandega osaleda.


Heade soovidega!

Ines Vaide
Hematoloog
Tel +372 5650 0074



This e-mail and any attachment may contain confidential and privileged = information. If you are not the intended recipient,please notify the = sender immediately by return e-mail, delete this e-mail and destroy any = copies. Any dissemination or use of this information by a person other than the intended recipients is unauthorized and may = be illegal.

------=_NextPart_000_006C_01DD5AE6.8958F7B0--